PANZERA, NOEMI
 Distribuzione geografica
Continente #
NA - Nord America 248
EU - Europa 151
AS - Asia 29
AF - Africa 1
OC - Oceania 1
Totale 430
Nazione #
US - Stati Uniti d'America 247
IE - Irlanda 66
IT - Italia 37
SE - Svezia 15
CN - Cina 13
DE - Germania 8
UA - Ucraina 8
CZ - Repubblica Ceca 5
GB - Regno Unito 5
TR - Turchia 5
VN - Vietnam 4
FI - Finlandia 3
SG - Singapore 3
IN - India 2
AT - Austria 1
AU - Australia 1
BE - Belgio 1
CI - Costa d'Avorio 1
ES - Italia 1
FR - Francia 1
IR - Iran 1
LB - Libano 1
PR - Porto Rico 1
Totale 430
Città #
Chandler 82
Dublin 66
Jacksonville 36
New York 16
Ashburn 12
L’Aquila 10
L'aquila 9
Lawrence 8
Princeton 8
Boardman 6
Ann Arbor 5
Brno 5
Izmir 5
Cagliari 4
Dong Ket 4
Wilmington 4
Beijing 3
Helsinki 3
Los Angeles 3
Shanghai 3
Singapore 3
Dearborn 2
Kitzingen 2
Nanjing 2
Pune 2
San Mateo 2
Woodbridge 2
Aquila 1
Barcelona 1
Bremen 1
Brisbane 1
Brussels 1
Cambridge 1
Casal di Principe 1
Chicago 1
Città di Castello 1
Des Moines 1
Edinburgh 1
Hebei 1
Houston 1
Kish 1
Kunming 1
Milan 1
San Juan 1
Shenyang 1
Spoltore 1
Stockholm 1
Suzhou 1
Tianjin 1
Tolmezzo 1
Vienna 1
Washington 1
Totale 332
Nome #
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 88
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 60
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 53
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 52
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 52
L'espressione del CD248 su cellule miofibroblastoidi può contribuire ad aggravare il danno vascolare in corso di Sclerosi sistemica 43
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 42
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 40
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 29
Totale 459
Categoria #
all - tutte 2.140
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.140


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202040 4 0 2 1 0 4 6 1 5 3 0 14
2020/202161 1 5 0 11 10 5 7 3 5 1 8 5
2021/202255 1 4 9 5 2 0 1 1 3 7 7 15
2022/2023199 11 17 6 32 9 18 1 14 82 0 9 0
2023/202480 17 1 3 2 7 30 0 4 1 3 2 10
2024/20256 6 0 0 0 0 0 0 0 0 0 0 0
Totale 459